$400.37+0.92% · 3M
Moving avg
1W+1.57%
1M+2.57%
3M+1.96%
6M+15.45%
YTD+13.02%
1Y+35.52%
3Y-15.07%
5Y+6.37%
52-week range
$273.7178% of range$436.24
Company health
Value5/6
Growth3/6
Profitability3/6
Health3/6
Dividend5/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1124%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$86.83B
Enterprise value
$102.72B
P/E ratio (TTM)
16.79x
P/S ratio (TTM)
0.41x
EV/EBITDA
12.83x
Per share & returns
EPS (TTM)
$22.78
Dividend yield
1.82%
Beta (1Y)
0.68
30-day change
+2.57%
Trading
Volume (24h)
215.56K
Previous close
$399.14
Shares outstanding
216.87M
About Elevance Health Inc.
Sector
Healthcare
Industry
Medical - Healthcare Plans
Exchange
NYSE
Symbol
ELV
Elevance Health Inc. is a large-cap healthcare company in the Medical - Healthcare Plans industry. Its shares are listed on NYSE (United States) and trade under the ticker ELV.
Frequently asked questions
What is Elevance Health Inc.'s market cap?
Elevance Health Inc. (ELV) has a market capitalization of $86.83B.
What is Elevance Health Inc.'s P/E ratio?
Elevance Health Inc. trades at a price-to-earnings (P/E) ratio of 16.79.
What exchange does ELV trade on?
ELV trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,218.39-0.15%
$1.15T cap
Johnson & JohnsonJNJ
$261.39+0.20%
$629.92B cap
AbbVie Inc.ABBV
$250.32+0.63%
$442.26B cap
UnitedHealth Group IncorporatedUNH
$402.17-0.84%
$365.22B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.77+1.39%
$332.86B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.76B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap